Featured Research

from universities, journals, and other organizations

Wide Use Leads To Push To Test Safety Of Four Herbs

Date:
July 28, 1999
Source:
National Institute Of Environmental Health Sciences
Summary:
Four herbal products - aloe vera, ginseng, kava kava and milk thistle - and a substance in vegetables thought to inhibit cancer have been recommended by a panel representing the federal health agencies for toxicity testing under the National Toxicology Program at the National Institute of Environmental Health Sciences.

Four herbal products - aloe vera, ginseng, kava kava and milk thistle - and a substance in vegetables thought to inhibit cancer have been recommended by a panel representing the federal health agencies for toxicity testing under the National Toxicology Program at the National Institute of Environmental Health Sciences.

Program officials said today that the National Cancer Institute nominated all five for testing because of their widespread or increasing use by the public. The officials said the substances were then reviewed and approved by the federal Interagency Committee for Chemical Evaluation and Coordination, which advises NTP's testing. Such recommendations are often made when the popularity of a relatively untested substance exposes large numbers of people. No data indicating a known problem is required for a nomination.

Before making a final decision to test the substances, NTP is requesting public comment and any additional scientific information be sent to Dr. William Eastin, NIEHS/NTP, Box 12233, Research Triangle Park, NC 27709, or email him at Eastin@NIEHS.NIH.gov by Sept. 7, 1999.

The four herbs are aloe vera, which is used as a dietary supplement as well as a cosmetic; ginseng, which is promoted for vigor; kava kava is used as a mood elevator, and milk thistle, is considered by some to have anti-cancer and liver-protective properties. The fifth nomination is for indole-3-carbinol, a substance in cruciferous vegetables such as broccoli, and thought to have potential to reduce the risk of cancer.

NTP, which is headquartered at NIEHS in Research Triangle Park, N.C., said that the current toxicity information on the substances is considered "inadequate." NTP also asked for comments on the interagency committee's recommendations to test:

* Ammonium molybdate, one of many soluble molybdenum compounds which workers and the general population may be exposed to.

* 5,6-benzoflavone, also known as Beta-napthaflavone, a synthetic compound similar to compounds naturally occurring in plants, a research substance that lacks drug industry sponsorship but might also have potential for reducing the risk of cancer.

* 1,3-Dichloro-2-butene, a high production industrial chemical with a potential for worker exposure and with a structural similarity to a known carcinogen.

* 3-Picoline, a high production industrial chemical.

Although all nine substances were nominated by health research agencies, nominations may also be made by businesses, unions and the public. A formal announcement of the request for comment is in the Federal Register vol. 64, no. 129, pp. 36704-36707.


Story Source:

The above story is based on materials provided by National Institute Of Environmental Health Sciences. Note: Materials may be edited for content and length.


Cite This Page:

National Institute Of Environmental Health Sciences. "Wide Use Leads To Push To Test Safety Of Four Herbs." ScienceDaily. ScienceDaily, 28 July 1999. <www.sciencedaily.com/releases/1999/07/990728073934.htm>.
National Institute Of Environmental Health Sciences. (1999, July 28). Wide Use Leads To Push To Test Safety Of Four Herbs. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/1999/07/990728073934.htm
National Institute Of Environmental Health Sciences. "Wide Use Leads To Push To Test Safety Of Four Herbs." ScienceDaily. www.sciencedaily.com/releases/1999/07/990728073934.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins